Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 871 of 6351
-
Could new tech replace the puffer test for asthma?
Diagnosis Recruiting nowThis trial aims to evaluate novel diagnostic technologies for asthma in 3 different pathways providing the necessary evidence-base to allow adoption into clinical practice: * Pathway 1 evaluates whether the technology can distinguish between people with asthma and healthy volunt…
Sponsor: Portsmouth Hospitals NHS Trust • Aim: Diagnosis
Last updated Jul 08, 2026 00:00 UTC
-
New combo therapy shows promise for Tough-to-Treat bile duct cancer
Disease control OngoingThis is a multi-center, open-label, randomized, phase 2/3 trial of the bispecific antibody CTX-009 plus paclitaxel versus paclitaxel in patients with previously treated, unresectable advanced or metastatic biliary tract cancers.
Phase 2/3 • Sponsor: Compass Therapeutics • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a new PET scan light up hidden adrenal tumors causing high blood pressure?
Diagnosis CompletedThe study was proposed to include 20 patients with clinical suspicion of primary aldosteronism for \[18F\]AlF-NOTA-pentixather PET/CT imaging and to analyze the specificity and sensitivity of \[18F\]AlF-NOTA-pentixather PET/CT for the diagnosis of APA by comparison with the final…
Sponsor: Sichuan Provincial People's Hospital • Aim: Diagnosis
Last updated Aug 20, 2026 00:00 UTC
-
Which fixation method best heals a reconstructed ACL?
Disease control OngoingInfluence of different tibial fixation methods in anterior cruciate ligament (ACL) reconstruction: bone integration, graft maturation, and clinical outcomes. Primary Objective To assess whether any of the four tibial fixation techniques is superior in terms of: Graft-bone inte…
Sponsor: Institut Català de Traumatologia i Medicina de l'Esport • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New drug aims to fix calcium levels in rare genetic disease
Disease control OngoingThe primary purpose of the study is to understand the effectiveness, safety, and tolerability of encaleret when compared to standard of care (SoC) treatment in participants with Autosomal Dominant Hypocalcemia Type 1 (ADH1).
Phase 3 • Sponsor: Calcilytix Therapeutics, Inc., a BridgeBio company • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Fish allergy cure? new trial tests codfish therapy in kids
Disease control OngoingAt present there is no cure for food allergy. People with a food allergy need to avoid the food they are allergic to in order to stay safe, but we know that accidental exposure is common. Researchers have begun to look at the effectiveness of 'oral immunotherapy' as a treatment f…
Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Could your phone help rewire binge-eating habits?
Disease control Recruiting nowThe purpose of this study is to identify the independent and combined effects of two types of self-monitoring and two types of micro-interventions when combined with standard cognitive behavioral treatment for bulimia nervosa (BN) and binge eating disorder (BED). The primary aims…
Sponsor: Nemours Children's Clinic • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
New device aims to suck out dangerous blood clots, sparing patients from Long-Term leg damage
Disease control Recruiting nowThis study is a prospective, multicenter, randomized controlled trial of an interventional strategy using the ClotTriever System to achieve and maintain vessel patency (ClotTriever Intervention Arm) versus conservative medical management using anticoagulation therapy alone (Conse…
Sponsor: Inari Medical • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New hope for rare, aggressive blood cancer: 3-Drug cocktail targets richter transformation
Disease control Recruiting nowThis phase II trial tests whether acalabrutinib, venetoclax, and durvalumab work in treating patients with Richter transformation from chronic lymphocytic leukemia or small lymphocytic lymphoma. Richter transformation is a rare condition in which chronic lymphocytic leukemia or s…
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New drug batoclimab aims to reduce eye bulging in thyroid eye disease
Disease control CompletedTo evaluate the efficacy of batoclimab 680 milligrams (mg) subcutaneous (SC) once a week (QW) for 12 weeks followed by 340 mg SC QW for 12 weeks versus placebo on proptosis responder rate at Week 24.
Phase 3 • Sponsor: Immunovant Sciences GmbH • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New hope for hard-to-treat stomach cancer? drug duo targets MET gene
Disease control Recruiting nowFor patients who failed primary chemotherapy with MET amplification, The efficacy and safety of the chemotherapy are evaluated by using dervalumab and saboritinib in combination.
Phase 2 • Sponsor: Jeeyun Lee • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New drug combo aims to wipe out hidden myeloma cells after transplant
Disease control Recruiting nowThis is a phase II study where patients will undergo isatuximab and lenalidomide maintenance if they are MRD-positive after Autologous Stem Cell Transplant (ASCT)
Phase 2 • Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Green tea extract may boost fertility in women with fibroids
Disease control OngoingThe objective of this study is to determine the effect of low caffeine green tea extract containing 45% epigallocatechin gallate (EGCG) on fibroids and subsequent pregnancy and live births in women seeking fertility treatment. The population will consist of 50 women desirous of …
Phase 3 • Sponsor: Yale University • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New pill shows promise against tough lung cancer in early trial
Disease control OngoingThe primary objective is to evaluate the efficacy/safety of lazertinib and to explore the resistance mechanism of lazertinib as first-line in patients with NSCLC harboring activating EGFR mutations.
Phase 2 • Sponsor: Sehhoon Park • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Sound waves open brain barrier to attack deadly childhood tumor
Disease control OngoingThe purpose of this study is to evaluate the safety and efficacy of targeted blood brain barrier disruption with Exablate Model 4000 Type 2.0/2.1 in combination with Doxorubicin therapy for the treatment of DIPG in pediatric patients
Phase 1/2 • Sponsor: InSightec • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a stomach muscle cut tame diabetes blood sugar?
Disease control OngoingThis study will assess changes in glycemic control in 40 patients with diabetes who undergo per-oral pyloromyotomy (POP) for medically refractory gastroparesis.
Sponsor: Matthew Allemang • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Texts at the right moment may curb Alcohol-Fueled partner violence
Prevention OngoingAcute alcohol intoxication is a robust predictor of intimate partner violence (IPV) perpetration for young adult men and women; therefore, interventions delivered proximally to drinking episodes - a period of high risk - are needed to reduce alcohol-facilitated IPV. This project …
Sponsor: Georgia State University • Aim: Prevention
Last updated Aug 29, 2026 00:00 UTC
-
Eye movements may reveal Autism's hidden signs
Diagnosis Recruiting nowThe goal of this observational study is to identify behavioral and physiological markers of social alterations in Autism Spectrum Disorders compared to Typically Developping peers. This single-centre study plan to use eye tracking to evaluate social disorders in Autism Spectrum D…
Sponsor: University Hospital, Tours • Aim: Diagnosis
Last updated Aug 30, 2026 00:00 UTC
-
New hope for NASH: drug targets liver scarring in advanced disease
Disease control OngoingThe purpose of this study is to measure improvements in liver fibrosis and inflammation with GSK4532990 compared with placebo in participants with NASH and advanced fibrosis on biopsy (F3 or F4). The study duration will be up to 76 weeks including the screening period. The treatm…
Phase 2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Badminton battles phone addiction: study tests sport as digital detox for teens
Disease control CompletedThe global surge in smartphone addiction (SA) represents a critical biopsychosocial risk for adolescents. This study evaluated the efficacy of a 12-week structured badminton intervention in alleviating SA among high school students and explored the psychosocial mechanisms underly…
Sponsor: Zonguldak Bulent Ecevit University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC